DOI QR코드

DOI QR Code

Improved postoperative recovery profile in pediatric oral rehabilitation with low-dose dexmedetomidine as an opioid substitute for general anesthesia: a randomized double-blind clinical trial

  • Naveen, Naik B (Department of Anaesthesia and Intensive Care, Post Graduate Institute of Medical Education and Research) ;
  • Jaiswal, Manoj Kumar (Department of Pedodontics and Preventive Dentistry, Post Graduate Institute of Medical Education and Research) ;
  • Ganesh, Venkata (Department of Anaesthesia and Intensive Care, Post Graduate Institute of Medical Education and Research) ;
  • Singh, Ajay (Department of Anaesthesia and Intensive Care, Post Graduate Institute of Medical Education and Research) ;
  • Meena, Shyam Charan (Department of Anaesthesia and Intensive Care, Post Graduate Institute of Medical Education and Research) ;
  • Amburu, Vamsidhar (Department of Critical Care and Emergency Medicine, Sir Ganga Ram Hospital) ;
  • Soni, Shiv Lal (Department of Anaesthesia and Intensive Care, Post Graduate Institute of Medical Education and Research)
  • Received : 2022.08.17
  • Accepted : 2022.09.08
  • Published : 2022.10.01

Abstract

Background: Low-dose dexmedetomidine may be a suitable alternative to opioids for pediatric ambulatory procedures under general anesthesia (GA). However, the recovery profile remains unclear. Herein, we aimed to evaluate the effects of low-dose dexmedetomidine on the recovery profile of children. Methods: Seventy-two children undergoing ambulatory oral rehabilitation under GA were randomly and equally distributed into two groups (D and F). Group D received an infusion of dexmedetomidine 0.25 ㎍/kg for 4 min for induction, followed by maintenance of 0.4 ㎍/kg/h. Group F received an infusion of fentanyl 1 ㎍/kg over 4 min for induction, followed by maintenance at 1 ㎍/kg/h. The primary outcome was the extubation time. The secondary outcomes were awakening time, end-tidal sevoflurane (ET-Sevo) requirement, change in hemodynamic parameters, Richmond Agitation-Sedation Scale (RASS), Children's Hospital of Eastern Ontario pain scale (CHEOPS) score, length of PACU stay, and incidence of adverse events. Results: Statistically significant differences were observed in the recovery profile between the groups: the median time for extubation was 3.65 (3.44-6.2) vs. 6.25 (4.21-7) minutes in groups D vs. F (P=0.001), respectively, while the corresponding awakening times were 19 (18.75-21) and 22.5 (22-24) minutes, respectively (P < 0.001). The mean ET-Sevo was low in group D (1.1 vs. 1.2; P < 0.001). The heart rate was significantly low across all time points in group D, without resulting in bradycardia. The median RASS and CHEOPS scores were also significantly lower in group D. No significant differences were observed in the mean arterial pressure, incidence of adverse events, or length of PACU stay. Conclusion: Low-dose dexmedetomidine was more effective than fentanyl as an opioid substitute at providing a better recovery profile in pediatric ambulatory oral rehabilitation under GA. Dexmedetomidine also significantly reduced sevoflurane consumption without causing adverse events or prolonging hospital stay.

Keywords

Acknowledgement

We would like to thank all pediatric patients and their parents/representatives who participated in this project.

References

  1. Wen PYF, Chen MX, Zhong YJ, Dong QQ, Wong HM. Global burden and inequality of dental caries, 1990 to 2019. J Dent Res 2022; 101: 392-9. https://doi.org/10.1177/00220345211056247
  2. Kassebaum NJ, Bernabe E, Dahiya M, Bhandari B, Murray CJ, Marcenes W. Global burden of untreated caries: a systematic review and metaregression. J Dent Res 2015; 94: 650-8. https://doi.org/10.1177/0022034515573272
  3. Oubenyahya H, Bouhabba N. General anesthesia in the management of early childhood caries: an overview. J Dent Anesth Pain Med 2019; 19: 313-22. https://doi.org/10.17245/jdapm.2019.19.6.313
  4. Koepke EJ, Manning EL, Miller TE, Ganesh A, Williams DGA, Manning MW. The rising tide of opioid use and abuse: the role of the anesthesiologist. Perioper Med (Lond) 2018; 7: 16. https://doi.org/10.1186/s13741-018-0097-4
  5. Kessler ER, Shah M, Gruschkus SK, Raju A. Cost and quality implications of opioid-based postsurgical pain control using administrative claims data from a large health system: opioid-related adverse events and their impact on clinical and economic outcomes. Pharmacotherapy 2013; 33: 383-91. https://doi.org/10.1002/phar.1223
  6. Bennett KG, Harbaugh CM, Hu HM, Vercler CJ, Buchman SR, Brummett CM, et al. Persistent opioid use among children, adolescents, and young adults after common cleft operation. J Craniofac Surg 2018; 29: 1697-701. https://doi.org/10.1097/SCS.0000000000004762
  7. Swartz MK. Opioids: a pediatric epidemic. J Pediatr Health Care 2018; 32: 115-6. https://doi.org/10.1016/j.pedhc.2018.01.002
  8. Mauermann E, Filitz J, Dolder P, Rentsch KM, Bandschapp O, Ruppen W. Does fentanyl lead to opioid-induced hyperalgesia in healthy volunteers? A double-blind, randomized, crossover trial. Anesthesiology 2016; 124: 453-63. https://doi.org/10.1097/ALN.0000000000000976
  9. Fletcher D, Martinez V. Opioid-induced hyperalgesia in patients after surgery: a systematic review and a meta-analysis. Br J Anaesth 2014; 112: 991-1004. https://doi.org/10.1093/bja/aeu137
  10. Chiem JL, Donohue LD, Martin LD, Low DK. An opioid-free anesthesia protocol for pediatric strabismus surgery: a quality improvement project. Pediatr Qual Saf 2021; 6: e462. https://doi.org/10.1097/pq9.0000000000000462
  11. Franz AM, Martin LD, Liston DE, Latham GJ, Richards MJ, Low DK. In pursuit of an opioid-free pediatric ambulatory surgery center: a quality improvement initiative. Anesth Analg 2021; 132: 788-97. https://doi.org/10.1213/ANE.0000000000004774
  12. Rizeq YK, Many BT, Vacek JC, Silver I, Goldstein SD, Abdullah F et al. Trends in perioperative opioid and non-opioid utilization during ambulatory surgery in children. Surgery 2019; 166: 172-6. https://doi.org/10.1016/j.surg.2019.04.005
  13. Mohamed M, Mason KP. Dexmedetomidine and ambulatory surgery. ASA Newsletter 2015; 79: 24-6.
  14. Mahmoud M, Mason KP. Dexmedetomidine: review, update, and future considerations of paediatric perioperative and periprocedural applications and limitations. Br J Anaesth 2015; 115: 171-82. https://doi.org/10.1093/bja/aev226
  15. Ganesh V, Luthra A, Amburu V, Naik BN, Singh A, Puri GD. Low-dose dexmedetomidine reduces median effective concentration (ec 50) of propofol more than fentanyl in unparalysed anaesthetised patients for i-gel insertion: a randomised controlled trial. Anaesth Crit Care Pain Med 2021; 40: 100815. https://doi.org/10.1016/j.accpm.2021.100815
  16. Erdil F, Demirbilek S, Begec Z, Ozturk E, Ulger MH, Ersoy MO. The effects of dexmedetomidine and fentanyl on emergence characteristics after adenoidectomy in children. Anaesth Intensive Care 2009; 37: 571-7. https://doi.org/10.1177/0310057X0903700405
  17. Chen F, Wang C, Lu Y, Huang M, Fu Z. Efficacy of different doses of dexmedetomidine as a rapid bolus for children: a double-blind, prospective, randomized study. BMC Anesthesiol 2018; 18: 103. https://doi.org/10.1186/s12871-018-0562-0
  18. Zhou M, Wang Q, Zhang Q, Liu Y, Zhan L, Shu A. Application of pre-injection of dexmedetomidine of different doses in pediatric intravenous general anesthesia without tracheal intubation. Exp Ther Med 2018; 15: 2973-7.
  19. Sun Y, Li Y, Sun Y, Wang X, Ye H, Yuan X. Dexmedetomidine effect on emergence agitation and delirium in children undergoing laparoscopic hernia repair: a preliminary study. J Int Med Res 2017; 45: 973-83. https://doi.org/10.1177/0300060517699467
  20. Xie Y, Du Y, Shi H, Sun J, Duan H, Yu J. Different doses of dexmedetomidine in children with non-tracheal intubation intravenous general anesthesia. Int J Clin Exp Med 2018; 11: 6215-21.
  21. Josephine C, Shariffuddin II, Chaw SH, Ng KWS, Ng KT. Hemodynamic response of high- and low-dose dexmedetomidine of pediatric in general anesthesia: a systematic review and meta-analysis of randomized controlled trials. Asian J Anesthesiol 2021; 59: 7-21.
  22. Kim J, Kim SY, Lee JH, Kang YR, Koo BN. Low-dose dexmedetomidine reduces emergence agitation after desflurane anaesthesia in children undergoing strabismus surgery. Yonsei Med J 2014; 55: 508-16. https://doi.org/10.3349/ymj.2014.55.2.508
  23. Sato M, Shirakami G, Tazuke-Nishimura M, Matsuura S, Tanimoto K, Fukuda K. Effect of single-dose dexmedetomidine on emergence agitation and recovery profiles after sevoflurane anesthesia in pediatric ambulatory surgery. J Anesth 2010; 24: 675-82. https://doi.org/10.1007/s00540-010-0976-4
  24. Shi M, Miao S, Gu T, Wang D, Zhang H, Liu J. Dexmedetomidine for the prevention of emergence delirium and postoperative behavioral changes in pediatric patients with sevoflurane anesthesia: a double-blind, randomized trial. Drug Des Devel Ther 2019; 13: 897-905. https://doi.org/10.2147/DDDT.S196075
  25. Jebaraj B, Ramachandran R, Rewari V, Trikha A, Chandralekha, Kumar R, et al. Feasibility of dexmedeto-midine as sole analgesic agent during robotic urological surgery: a pilot study. J Anaesthesiol Clin Pharmacol 2017; 33: 187-92. https://doi.org/10.4103/0970-9185.209753
  26. Chen YP, Hsieh CY, Hsu WT, Wu FY, Shih WY. A 10-year trend of dental treatments under general anesthesia of children in Taipei Veterans General Hospital. J Chin Med Assoc 2017; 80: 262-8. https://doi.org/10.1016/j.jcma.2016.11.001
  27. van Hoorn CE, Flint RB, Skowno J, Davies P, Engelhardt T, Lalwani K et al. Off-label use of dexmedetomidine in paediatric anaesthesiology: an international survey of 791 (paediatric) anaesthesiologists. Eur J Clin Pharmacol 2021; 77: 625-35. https://doi.org/10.1007/s00228-020-03028-2
  28. He L, Wang X, Zheng S. Effects of dexmedetomidine on sevoflurane requirement for 50% excellent tracheal intubation in children: a randomized, double-blind comparison. Paediatr Anaesth 2014; 24: 987-93. https://doi.org/10.1111/pan.12430
  29. Mason KP, Lerman J. Review article: dexmedetomidine in children: current knowledge and future applications. Anesth Analg 2011; 113: 1129-42. https://doi.org/10.1213/ane.0b013e31822b8629
  30. Gong M, Man Y, Fu Q. Incidence of bradycardia in pediatric patients receiving dexmedetomidine anesthesia: a meta-analysis. Int J Clin Pharm 2017; 39: 139-47. https://doi.org/10.1007/s11096-016-0411-5
  31. Videira RL, Ferreira RM. Dexmedetomidine and asystole. Anesthesiology 2004; 101: 1479-80. https://doi.org/10.1097/00000542-200412000-00037
  32. Ingersoll-Weng E, Manecke GR Jr, Thistlethwaite PA. Dexmedetomidine and cardiac arrest. Anesthesiology 2004; 100: 738-9. https://doi.org/10.1097/00000542-200403000-00040
  33. Zhang X, Bai Y, Shi M, Ming S, Jin X, Xie Y. Effect of different administration and dosage of dexmedetomidine in the reduction of emergence agitation in children: a meta-analysis of randomized controlled trials with sequential trial analysis. Transl Pediatr 2021; 10: 929-57. https://doi.org/10.21037/tp-21-105
  34. Tang W, He D, Liu Y. Effect of Dexmedetomidine in children undergoing general anaesthesia with sevoflurane: a meta-analysis and systematic review. J Int Med Res 2020; 48: 300060520927530.
  35. Yang X, Hu Z, Peng F, Chen G, Zhou Y, Yang Q, et al. Effects of dexmedetomidine on emergence agitation and recovery quality among children undergoing surgery under general anesthesia: a meta-analysis of randomized controlled trials. Front Pediatr 2020; 8: 580226 https://doi.org/10.3389/fped.2020.580226